Shipping on Thin Ice: $35 Billion Lost Each Year to Temperature Failures in Pharma Logistics
Every year, the biopharmaceutical industry absorbs an alarming $35 billion in losses — not due to R&D or marketing missteps, but from temperature-control failures in the supply chain. Shockingly, 1 in 5 temperature-sensitive pharma products are damaged during transit, leading to spoilage, delays, regulatory issues, and worst of all, jeopardized patient outcomes. In an industry where precision is everything, these losses are unacceptable — and avoidable. Here are six reasons why pharma and life sciences companies must adopt track and trace technology in 2025 — not as an enhancement, but as a necessity. 1. Real-Time Oversight of Product Conditions In a landscape where delays can mean millions lost or lives affected, real-time tracking is essential. Modern track-and-trace tools offer live updates on location, temperature, and shipment integrity — alerting teams to potential threats before they escalate. If a biologic is stranded without proper refrigera...